<DOC>
	<DOCNO>NCT01234883</DOCNO>
	<brief_summary>The primary objective study compare efficacy safety use multiple electrolyte solution use saline treatment moderate severe dehydration due acute gastroenteritis ( AGE ) child .</brief_summary>
	<brief_title>Intravenous ( IV ) Solutions Dehydration Children With Gastroenteritis</brief_title>
	<detailed_description>The primary objective study compare efficacy safety use Plasma Lyte A use NS treatment moderate severe dehydration amelioration metabolic acidosis due AGE child ( ≥ 6 month &lt; 11 year age ) measure serum bicarbonate level .</detailed_description>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Dehydration</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . AGE ( etiology : viral ) result presentation ED deem need IV rehydration . In 24 hour prior presentation , subject experience least 3 episode diarrhea ( loose and/or watery stool ) and/or nonbilious vomit . 2 . Moderate severe dehydration ( assessed Gorelick score13 ≥ 4 3 . ≥ 6 month &lt; 11 year age . 4 . Healthy except underlie etiology AGE . 5 . Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) approve write ICFs privacy language per national regulation ( eg , Health Insurance Portability Accountability Act [ HIPAA ] , Personal Information Protection Electronic Documents Act [ PIPEDA ] ) obtain parent/guardian prior studyrelated procedure . 1 . AGE require IV rehydration per clinician . 2 . Gorelick score ≤ 3 3 . Bilious vomit . 4 . Received &gt; 20 mL/kg IV fluid bolus within 4 hour prior study enrollment ( ie , Hour 4 Hour 0 ) . 5 . Diarrhea last &gt; 7 day prior presentation ED . 6 . Chronic vomit disorder . 7 . Grossly bloody diarrhea . 8 . Chronic diarrheal disorder . 9 . Known hyponatremia ( sodium &lt; 130 mmol/L [ &lt; 130 mEq/L ] ) within 72 hour prior enrollment . 10 . Known hypernatremia ( sodium &gt; 155 mmol/L [ &gt; 155 mEq/L ] ) within 72 hour prior enrollment . 11 . Known hypokalemia ( potassium &lt; 3.0 mmol/L [ &lt; 3.0 mEq/L ] ) within 72 hour prior enrollment . 12 . Known hyperkalemia ( potassium &gt; 5.5 mmol/L [ &gt; 5.5 mEq/L ] ) within 72 hour prior enrollment . 13 . The use prohibit medication : Antacids within 24 hour prior presentation ED study . Antidiarrhea medication within 24 hour prior presentation ED study . The systemic use corticosteroids/corticotropins prohibit within 72 hour enrollment . 14 . Chronic health condition affect ability tolerate fluid result electrolyte abnormality ( eg , chronic renal , cardiac , pulmonary diagnosis ) , abnormalities sodium potassium handling ( eg , endocrine disorder , medication ) . 15 . Any reason urgent emergency hospital admission ED stay &gt; 12 hour within 14 day precede presentation ED . 16 . Any medical condition likely interfere subject 's ability fully complete protocolspecified intervention , ability undergo protocolspecified assessment , likely prolong subject 's need medical attention beyond require treatment dehydration . 17 . Participation study investigational drug device concomitantly within 30 day prior enrollment study , include previous enrollment study . 18 . Subject &gt; 50 % expect chance die within 6 month , Investigator 's opinion . 19 . Known hypersensitivity either investigational product . 20 . Other serious acute active condition , Investigator 's opinion , preclude participation study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>dehydration</keyword>
	<keyword>gastroenteritis</keyword>
</DOC>